|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021051,
umls-concept:C0023981,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0079411,
umls-concept:C0205225,
umls-concept:C0220825,
umls-concept:C0242172,
umls-concept:C0812246,
umls-concept:C0936233,
umls-concept:C1602433,
umls-concept:C1709323,
umls-concept:C1710304
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-11-13
|
|
pubmed:abstractText |
Flebogamma 5% dual inactivation and filtration (DIF) is the next generation of Flebogamma. Flebogamma was first licensed in 1992. The new preparation features additional viral inactivation and removal steps to enhance safety margins.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0271-9142
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
628-33
|
|
pubmed:dateRevised |
2011-2-11
|
|
pubmed:meshHeading |
pubmed-meshheading:17909953-Adolescent,
pubmed-meshheading:17909953-Adult,
pubmed-meshheading:17909953-Aged,
pubmed-meshheading:17909953-Female,
pubmed-meshheading:17909953-Filtration,
pubmed-meshheading:17909953-Follow-Up Studies,
pubmed-meshheading:17909953-Humans,
pubmed-meshheading:17909953-Immunoglobulin Fab Fragments,
pubmed-meshheading:17909953-Immunoglobulin Fc Fragments,
pubmed-meshheading:17909953-Immunoglobulins, Intravenous,
pubmed-meshheading:17909953-Immunologic Deficiency Syndromes,
pubmed-meshheading:17909953-Male,
pubmed-meshheading:17909953-Middle Aged,
pubmed-meshheading:17909953-Prospective Studies
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A multicenter, prospective, open label, historically controlled clinical trial to evaluate efficacy and safety in primary immunodeficiency diseases (PID) patients of Flebogamma 5% DIF, the next generation of Flebogamma.
|
|
pubmed:affiliation |
Case Western Reserve University, Cleveland, OH, USA. melvin.berger@uhhospitals.org
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
